Back to Search
Start Over
[Management of extensive disease small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party].
- Source :
-
Revue medicale de Bruxelles [Rev Med Brux] 2014 May-Jun; Vol. 35 (3), pp. 164-8. - Publication Year :
- 2014
-
Abstract
- The present updated guidelines on the management of extensive disease small cell lung cancer (SCLC) formulated by the ELCWP are designed to answer the following questions : 1) What is the definition of extensive disease? 2) What are the active drugs? 3) What is the best induction regimen? 4) Is there a role for maintenance chemotherapy? 5) Is there a role for dose-intensive chemotherapy (without administration of hematopoietic growth factors)-? 6) Is there a role for the use of haematopoietic growth factors and stem cells support? 7) Is there a role for alternating or sequential chemotherapy? 8) Is there a role for biological treatments? 9) Is there a place for second-line chemotherapy? 10) Is there a role for preventive brain irradiation (PCI)?
- Subjects :
- Brain Neoplasms prevention & control
Europe
Evidence-Based Medicine
Humans
Lung Neoplasms pathology
Meta-Analysis as Topic
Neoplasm Staging
Randomized Controlled Trials as Topic
Small Cell Lung Carcinoma pathology
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Chemotherapy, Adjuvant methods
Lung Neoplasms drug therapy
Small Cell Lung Carcinoma drug therapy
Subjects
Details
- Language :
- French
- ISSN :
- 0035-3639
- Volume :
- 35
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Revue medicale de Bruxelles
- Publication Type :
- Academic Journal
- Accession number :
- 25102583